Rank | Gene Set | Z-score |
---|---|---|
1 | response to peptidoglycan (GO:0032494) | 6.89587712 |
2 | neutrophil activation involved in immune response (GO:0002283) | 6.58065158 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.52222328 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.52222328 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.52222328 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.52222328 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.52222328 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.52222328 |
9 | leukocyte aggregation (GO:0070486) | 6.47792154 |
10 | negative regulation of cell killing (GO:0031342) | 5.50555379 |
11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.50555379 |
12 | respiratory burst (GO:0045730) | 5.39563416 |
13 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.19091458 |
14 | positive regulation of mast cell activation (GO:0033005) | 4.87071587 |
15 | granulocyte activation (GO:0036230) | 4.82356890 |
16 | positive regulation of mast cell degranulation (GO:0043306) | 4.81922217 |
17 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.81922217 |
18 | neutrophil activation (GO:0042119) | 4.78731552 |
19 | response to host immune response (GO:0052572) | 4.74086203 |
20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.74086203 |
21 | macrophage activation involved in immune response (GO:0002281) | 4.59974258 |
22 | regulation of mast cell degranulation (GO:0043304) | 4.57792858 |
23 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.50187611 |
24 | response to host (GO:0075136) | 4.34392042 |
25 | response to host defenses (GO:0052200) | 4.34392042 |
26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.34392042 |
27 | immunoglobulin mediated immune response (GO:0016064) | 4.30516477 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.29301743 |
29 | negative regulation of interleukin-12 production (GO:0032695) | 4.26860366 |
30 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.26716778 |
31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.26092429 |
32 | regulation of mast cell activation (GO:0033003) | 4.18935274 |
33 | superoxide anion generation (GO:0042554) | 4.18306205 |
34 | detection of other organism (GO:0098543) | 4.16479604 |
35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.16018786 |
36 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.10294756 |
37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.09126680 |
38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.02168201 |
39 | response to muramyl dipeptide (GO:0032495) | 4.00042327 |
40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.97099258 |
41 | reactive oxygen species biosynthetic process (GO:1903409) | 3.95786935 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.93293018 |
43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.90090891 |
44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.86967195 |
45 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.85853955 |
46 | detection of bacterium (GO:0016045) | 3.84385939 |
47 | regulation of leukocyte degranulation (GO:0043300) | 3.83828718 |
48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.83359807 |
49 | regulation of chemokine biosynthetic process (GO:0045073) | 3.81924626 |
50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.77744469 |
51 | * neutrophil mediated immunity (GO:0002446) | 3.75554480 |
52 | negative regulation of mast cell activation (GO:0033004) | 3.75230575 |
53 | myeloid cell activation involved in immune response (GO:0002275) | 3.74197514 |
54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.74178041 |
55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70099176 |
56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.68961393 |
57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.67338456 |
58 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.63994246 |
59 | response to fungus (GO:0009620) | 3.63177611 |
60 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.61231014 |
61 | positive regulation of heat generation (GO:0031652) | 3.60664705 |
62 | microglial cell activation (GO:0001774) | 3.60616655 |
63 | positive regulation of leukocyte degranulation (GO:0043302) | 3.59144105 |
64 | detection of molecule of bacterial origin (GO:0032490) | 3.58001653 |
65 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.56151963 |
66 | * neutrophil chemotaxis (GO:0030593) | 3.55847773 |
67 | regulation of fever generation (GO:0031620) | 3.55354008 |
68 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54531358 |
69 | germinal center formation (GO:0002467) | 3.53264635 |
70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.50328198 |
71 | positive regulation of interferon-alpha production (GO:0032727) | 3.48530915 |
72 | * neutrophil migration (GO:1990266) | 3.45237639 |
73 | negative regulation of growth of symbiont in host (GO:0044130) | 3.44636076 |
74 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.44636076 |
75 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.44636076 |
76 | regulation of growth of symbiont in host (GO:0044126) | 3.44636076 |
77 | leukocyte cell-cell adhesion (GO:0007159) | 3.44156036 |
78 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43317122 |
79 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41376959 |
80 | regulation of interferon-alpha production (GO:0032647) | 3.40548451 |
81 | detection of external biotic stimulus (GO:0098581) | 3.40141803 |
82 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.39580911 |
83 | defense response to protozoan (GO:0042832) | 3.38543377 |
84 | leukotriene metabolic process (GO:0006691) | 3.32988539 |
85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32697742 |
86 | macrophage activation (GO:0042116) | 3.31879033 |
87 | cellular response to zinc ion (GO:0071294) | 3.31610524 |
88 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28503906 |
89 | T-helper 1 type immune response (GO:0042088) | 3.28091937 |
90 | B cell mediated immunity (GO:0019724) | 3.27088939 |
91 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.26207702 |
92 | response to interleukin-15 (GO:0070672) | 3.25290379 |
93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22279418 |
94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.18915533 |
95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.17700132 |
96 | regulation of tolerance induction (GO:0002643) | 3.17139270 |
97 | regulation of regulated secretory pathway (GO:1903305) | 3.16944630 |
98 | defense response to fungus (GO:0050832) | 3.16441341 |
99 | negative regulation of interleukin-1 production (GO:0032692) | 3.15717892 |
100 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15666470 |
101 | negative regulation of interleukin-6 production (GO:0032715) | 3.13993678 |
102 | detection of biotic stimulus (GO:0009595) | 3.13155733 |
103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.11474245 |
104 | * cellular extravasation (GO:0045123) | 3.10688228 |
105 | * granulocyte chemotaxis (GO:0071621) | 3.10133520 |
106 | regulation of macrophage cytokine production (GO:0010935) | 3.08123962 |
107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07348562 |
108 | chronic inflammatory response (GO:0002544) | 3.03893342 |
109 | phagosome maturation (GO:0090382) | 3.03264020 |
110 | response to protozoan (GO:0001562) | 3.03083551 |
111 | * granulocyte migration (GO:0097530) | 3.02327070 |
112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.01329412 |
113 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.00668525 |
114 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.98924333 |
115 | leukocyte degranulation (GO:0043299) | 2.98639274 |
116 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.97912723 |
117 | * myeloid leukocyte mediated immunity (GO:0002444) | 2.97231413 |
118 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.96467307 |
119 | sequestering of metal ion (GO:0051238) | 2.95914240 |
120 | regulation of T cell tolerance induction (GO:0002664) | 2.93550256 |
121 | regulation of B cell differentiation (GO:0045577) | 2.93343710 |
122 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93104743 |
123 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92689638 |
124 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.92333905 |
125 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.91879475 |
126 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91862112 |
127 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91862112 |
128 | negative regulation of interleukin-17 production (GO:0032700) | 2.91692555 |
129 | cellular response to type I interferon (GO:0071357) | 2.91345737 |
130 | type I interferon signaling pathway (GO:0060337) | 2.91345737 |
131 | myeloid leukocyte activation (GO:0002274) | 2.90506904 |
132 | cellular response to interleukin-15 (GO:0071350) | 2.90421131 |
133 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.89936591 |
134 | positive regulation of interferon-beta production (GO:0032728) | 2.89579191 |
135 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89469358 |
136 | response to type I interferon (GO:0034340) | 2.88634443 |
137 | dendritic cell migration (GO:0036336) | 2.88496609 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.20804091 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.65721627 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81675933 |
4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28611677 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.22927868 |
6 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.09461483 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.00290131 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.97267518 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77602769 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.61644990 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.53611077 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20365454 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84994357 |
14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.80595353 |
15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.74346237 |
16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72507848 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.70029548 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.68720165 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57477686 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.55148169 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.52445421 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40137986 |
23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27369591 |
24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27177781 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20587571 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95588471 |
27 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94208246 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92961348 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90111860 |
30 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87821778 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87510807 |
32 | MYB_26560356_Chip-Seq_TH2_Human | 1.87012147 |
33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84139244 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83244631 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82388617 |
36 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.81385653 |
37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75321782 |
38 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71574962 |
39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70737019 |
40 | MAF_26560356_Chip-Seq_TH1_Human | 1.67415657 |
41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66790565 |
42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65830808 |
43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62350140 |
44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57001227 |
45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53924427 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52389832 |
47 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50713520 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47621447 |
49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46067016 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44570157 |
51 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43674962 |
52 | MYB_26560356_Chip-Seq_TH1_Human | 1.39012792 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37940298 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34300554 |
55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33307828 |
56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29257274 |
57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28979923 |
58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28461304 |
59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28405143 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24551952 |
61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23992242 |
62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23864669 |
63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23510491 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21458269 |
65 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.18961637 |
66 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17494723 |
67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09727584 |
68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03384646 |
69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02847541 |
70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02097803 |
71 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02001815 |
72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00989013 |
73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00338765 |
74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99574383 |
75 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98796191 |
76 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92609460 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91957644 |
78 | MYC_22102868_ChIP-Seq_BL_Human | 0.89769762 |
79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87620436 |
80 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87542813 |
81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85375669 |
82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84800378 |
83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83832920 |
84 | MAF_26560356_Chip-Seq_TH2_Human | 0.83678386 |
85 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83079473 |
86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82947329 |
87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82543613 |
88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82266532 |
89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82229299 |
90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81420187 |
91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80670636 |
92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80287421 |
93 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80034102 |
94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78969749 |
95 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76586663 |
96 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75839156 |
97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.75472215 |
98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75356928 |
99 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.74496226 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74465886 |
101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72554559 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71378437 |
103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.70565463 |
104 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68821918 |
105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66958560 |
106 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.66448903 |
107 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.63740604 |
108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61737430 |
109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.61033295 |
110 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.61033295 |
111 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.60836918 |
112 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.60737177 |
113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59734853 |
114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.57168385 |
115 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.56939378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003436_decreased_susceptibility_to | 4.75453314 |
2 | MP0003303_peritoneal_inflammation | 4.25293292 |
3 | MP0009785_altered_susceptibility_to | 4.19249888 |
4 | MP0001835_abnormal_antigen_presentation | 3.83393230 |
5 | MP0002419_abnormal_innate_immunity | 3.68858262 |
6 | MP0002148_abnormal_hypersensitivity_rea | 3.53131686 |
7 | MP0003724_increased_susceptibility_to | 3.45401615 |
8 | MP0005000_abnormal_immune_tolerance | 3.18034764 |
9 | MP0005025_abnormal_response_to | 3.08052704 |
10 | MP0009278_abnormal_bone_marrow | 2.98343388 |
11 | MP0002452_abnormal_antigen_presenting | 2.60204180 |
12 | MP0001790_abnormal_immune_system | 2.57664067 |
13 | MP0005387_immune_system_phenotype | 2.57664067 |
14 | MP0001533_abnormal_skeleton_physiology | 2.50478814 |
15 | MP0004510_myositis | 2.49512044 |
16 | MP0002723_abnormal_immune_serum | 2.42954735 |
17 | MP0000343_altered_response_to | 2.40603122 |
18 | MP0001800_abnormal_humoral_immune | 2.38191347 |
19 | MP0001819_abnormal_immune_cell | 2.30661889 |
20 | MP0002420_abnormal_adaptive_immunity | 2.29935720 |
21 | MP0009764_decreased_sensitivity_to | 2.27243699 |
22 | MP0000685_abnormal_immune_system | 2.22968988 |
23 | MP0006082_CNS_inflammation | 2.21424167 |
24 | MP0005464_abnormal_platelet_physiology | 2.14011643 |
25 | MP0002405_respiratory_system_inflammati | 2.08886317 |
26 | MP0001853_heart_inflammation | 2.07549254 |
27 | MP0005671_abnormal_response_to | 2.01550822 |
28 | MP0003075_altered_response_to | 2.01499182 |
29 | MP0001845_abnormal_inflammatory_respons | 2.00899969 |
30 | MP0001545_abnormal_hematopoietic_system | 1.94988739 |
31 | MP0005397_hematopoietic_system_phenotyp | 1.94988739 |
32 | MP0004947_skin_inflammation | 1.87004996 |
33 | MP0005058_abnormal_lysosome_morphology | 1.84433540 |
34 | MP0005167_abnormal_blood-brain_barrier | 1.82817330 |
35 | MP0003448_altered_tumor_morphology | 1.78400324 |
36 | MP0000858_altered_metastatic_potential | 1.68333095 |
37 | MP0003183_abnormal_peptide_metabolism | 1.67624136 |
38 | MP0008004_abnormal_stomach_pH | 1.65613607 |
39 | MP0008469_abnormal_protein_level | 1.63154726 |
40 | MP0003828_pulmonary_edema | 1.61432734 |
41 | MP0000716_abnormal_immune_system | 1.59531459 |
42 | MP0010155_abnormal_intestine_physiology | 1.58521894 |
43 | MP0002398_abnormal_bone_marrow | 1.51014696 |
44 | MP0005076_abnormal_cell_differentiation | 1.49522495 |
45 | MP0003172_abnormal_lysosome_physiology | 1.49169695 |
46 | MP0002277_abnormal_respiratory_mucosa | 1.47981154 |
47 | MP0005166_decreased_susceptibility_to | 1.43746510 |
48 | MP0003191_abnormal_cellular_cholesterol | 1.40551295 |
49 | MP0003300_gastrointestinal_ulcer | 1.38608230 |
50 | MP0009333_abnormal_splenocyte_physiolog | 1.35735137 |
51 | MP0005310_abnormal_salivary_gland | 1.33853381 |
52 | MP0005164_abnormal_response_to | 1.33015162 |
53 | MP0002006_tumorigenesis | 1.30766976 |
54 | MP0002138_abnormal_hepatobiliary_system | 1.29158390 |
55 | MP0002429_abnormal_blood_cell | 1.28663802 |
56 | MP0002933_joint_inflammation | 1.28209818 |
57 | MP0008260_abnormal_autophagy | 1.27136217 |
58 | MP0000689_abnormal_spleen_morphology | 1.26894928 |
59 | MP0002998_abnormal_bone_remodeling | 1.24542171 |
60 | MP0000465_gastrointestinal_hemorrhage | 1.24438888 |
61 | MP0005390_skeleton_phenotype | 1.23213346 |
62 | MP0003866_abnormal_defecation | 1.21534579 |
63 | MP0002722_abnormal_immune_system | 1.18810219 |
64 | MP0001851_eye_inflammation | 1.12939234 |
65 | MP0004381_abnormal_hair_follicle | 1.12432144 |
66 | MP0003566_abnormal_cell_adhesion | 1.07535337 |
67 | MP0004808_abnormal_hematopoietic_stem | 1.07167866 |
68 | MP0003453_abnormal_keratinocyte_physiol | 0.99006960 |
69 | MP0001873_stomach_inflammation | 0.98781206 |
70 | MP0005174_abnormal_tail_pigmentation | 0.98685929 |
71 | MP0003186_abnormal_redox_activity | 0.97387598 |
72 | MP0004883_abnormal_blood_vessel | 0.96388892 |
73 | MP0003656_abnormal_erythrocyte_physiolo | 0.96161484 |
74 | MP0004782_abnormal_surfactant_physiolog | 0.93802223 |
75 | MP0009840_abnormal_foam_cell | 0.92112892 |
76 | MP0000604_amyloidosis | 0.90857717 |
77 | MP0002396_abnormal_hematopoietic_system | 0.89764730 |
78 | MP0009763_increased_sensitivity_to | 0.88084139 |
79 | MP0010307_abnormal_tumor_latency | 0.87955290 |
80 | MP0003045_fibrosis | 0.86479832 |
81 | MP0001663_abnormal_digestive_system | 0.84322859 |
82 | MP0002332_abnormal_exercise_endurance | 0.82446957 |
83 | MP0000569_abnormal_digit_pigmentation | 0.81647303 |
84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78291132 |
85 | MP0000249_abnormal_blood_vessel | 0.75581455 |
86 | MP0005451_abnormal_body_composition | 0.74874464 |
87 | MP0003690_abnormal_glial_cell | 0.74071741 |
88 | MP0010352_gastrointestinal_tract_polyps | 0.73202668 |
89 | MP0003279_aneurysm | 0.72747901 |
90 | MP0000490_abnormal_crypts_of | 0.72042079 |
91 | MP0002009_preneoplasia | 0.70237424 |
92 | MP0005023_abnormal_wound_healing | 0.70133140 |
93 | MP0003795_abnormal_bone_structure | 0.69431512 |
94 | MP0004484_altered_response_of | 0.69345101 |
95 | MP0005388_respiratory_system_phenotype | 0.65444074 |
96 | MP0002133_abnormal_respiratory_system | 0.65444074 |
97 | MP0002254_reproductive_system_inflammat | 0.65045228 |
98 | MP0002166_altered_tumor_susceptibility | 0.62053811 |
99 | MP0008874_decreased_physiological_sensi | 0.61150009 |
100 | MP0003763_abnormal_thymus_physiology | 0.60712865 |
101 | MP0003806_abnormal_nucleotide_metabolis | 0.60162302 |
102 | MP0006054_spinal_hemorrhage | 0.57216949 |
103 | MP0002132_abnormal_respiratory_system | 0.56726676 |
104 | MP0000015_abnormal_ear_pigmentation | 0.54944929 |
105 | MP0000371_diluted_coat_color | 0.54145041 |
106 | MP0000703_abnormal_thymus_morphology | 0.53420559 |
107 | MP0001958_emphysema | 0.52611686 |
108 | MP0008873_increased_physiological_sensi | 0.52480623 |
109 | MP0001191_abnormal_skin_condition | 0.52473530 |
110 | MP0000920_abnormal_myelination | 0.50525813 |
111 | MP0002019_abnormal_tumor_incidence | 0.50334819 |
112 | MP0004130_abnormal_muscle_cell | 0.50319236 |
113 | MP0005376_homeostasis/metabolism_phenot | 0.49326890 |
114 | MP0003091_abnormal_cell_migration | 0.47480960 |
115 | MP0000767_abnormal_smooth_muscle | 0.46976032 |
116 | MP0009765_abnormal_xenobiotic_induced | 0.46500389 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 8.58648606 |
2 | Eczematoid dermatitis (HP:0000976) | 7.92314801 |
3 | Recurrent bacterial skin infections (HP:0005406) | 7.59594850 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 7.09527866 |
5 | Abnormality of macrophages (HP:0004311) | 5.88600351 |
6 | Stomatitis (HP:0010280) | 5.81243937 |
7 | Mediastinal lymphadenopathy (HP:0100721) | 5.78370605 |
8 | Myositis (HP:0100614) | 5.34861859 |
9 | Chronic obstructive pulmonary disease (HP:0006510) | 5.13387067 |
10 | Obstructive lung disease (HP:0006536) | 5.13387067 |
11 | Orchitis (HP:0100796) | 5.12466204 |
12 | Retrobulbar optic neuritis (HP:0100654) | 4.88644907 |
13 | Optic neuritis (HP:0100653) | 4.88644907 |
14 | Gingivitis (HP:0000230) | 4.63905247 |
15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.58597957 |
16 | Recurrent skin infections (HP:0001581) | 4.47587297 |
17 | Recurrent fungal infections (HP:0002841) | 4.12511054 |
18 | Urticaria (HP:0001025) | 3.96659615 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.86109962 |
20 | Vacuolated lymphocytes (HP:0001922) | 3.71756703 |
21 | Cellulitis (HP:0100658) | 3.53034699 |
22 | Spontaneous hematomas (HP:0007420) | 3.51821608 |
23 | Vasculitis (HP:0002633) | 3.50857960 |
24 | Meningitis (HP:0001287) | 3.47341172 |
25 | Keratoconjunctivitis sicca (HP:0001097) | 3.13096240 |
26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09050086 |
27 | Interstitial pulmonary disease (HP:0006530) | 3.08194658 |
28 | Increased cerebral lipofuscin (HP:0011813) | 3.08154152 |
29 | Systemic lupus erythematosus (HP:0002725) | 3.00202059 |
30 | Periodontitis (HP:0000704) | 2.96763877 |
31 | Pulmonary infiltrates (HP:0002113) | 2.96110025 |
32 | Pustule (HP:0200039) | 2.94467966 |
33 | Hemoptysis (HP:0002105) | 2.81435387 |
34 | Keratoconjunctivitis (HP:0001096) | 2.81416792 |
35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80798406 |
36 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80798406 |
37 | Arterial thrombosis (HP:0004420) | 2.80640808 |
38 | Recurrent viral infections (HP:0004429) | 2.76783866 |
39 | Recurrent pneumonia (HP:0006532) | 2.75045844 |
40 | Hypochromic microcytic anemia (HP:0004840) | 2.73240859 |
41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.69693601 |
42 | T lymphocytopenia (HP:0005403) | 2.67558426 |
43 | Osteomyelitis (HP:0002754) | 2.66320775 |
44 | Abnormality of T cell number (HP:0011839) | 2.61453023 |
45 | Leukocytosis (HP:0001974) | 2.57915557 |
46 | Basal ganglia calcification (HP:0002135) | 2.51147649 |
47 | Prostate neoplasm (HP:0100787) | 2.50976136 |
48 | Hypochromic anemia (HP:0001931) | 2.50571825 |
49 | Disinhibition (HP:0000734) | 2.50457378 |
50 | Hematochezia (HP:0002573) | 2.48140668 |
51 | Gingival bleeding (HP:0000225) | 2.46238174 |
52 | Dysostosis multiplex (HP:0000943) | 2.45412445 |
53 | Petechiae (HP:0000967) | 2.45337801 |
54 | Axonal loss (HP:0003447) | 2.42955182 |
55 | Abnormality of the peritoneum (HP:0002585) | 2.41858995 |
56 | Agnosia (HP:0010524) | 2.38061593 |
57 | Increased IgM level (HP:0003496) | 2.37967271 |
58 | Poor head control (HP:0002421) | 2.37866403 |
59 | Joint hemorrhage (HP:0005261) | 2.36299535 |
60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32786430 |
61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30747939 |
62 | Gastrointestinal infarctions (HP:0005244) | 2.29245417 |
63 | Neoplasm of head and neck (HP:0012288) | 2.27333347 |
64 | Esophageal neoplasm (HP:0100751) | 2.27333347 |
65 | Chest pain (HP:0100749) | 2.26654753 |
66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26286170 |
67 | Amyloidosis (HP:0011034) | 2.26220563 |
68 | Vertigo (HP:0002321) | 2.24801953 |
69 | Granulocytopenia (HP:0001913) | 2.24768650 |
70 | Abnormality of T cells (HP:0002843) | 2.23031912 |
71 | Sepsis (HP:0100806) | 2.22903601 |
72 | Thick nail (HP:0001805) | 2.20645855 |
73 | Chronic otitis media (HP:0000389) | 2.20237369 |
74 | Epistaxis (HP:0000421) | 2.19866893 |
75 | Loss of speech (HP:0002371) | 2.19334185 |
76 | Tetraparesis (HP:0002273) | 2.18502316 |
77 | Pulmonary embolism (HP:0002204) | 2.17600018 |
78 | Abnormality of the pleura (HP:0002103) | 2.17367946 |
79 | Increased serum ferritin (HP:0003281) | 2.16969054 |
80 | Skin ulcer (HP:0200042) | 2.12347158 |
81 | Keratitis (HP:0000491) | 2.11760187 |
82 | Anorexia (HP:0002039) | 2.11453287 |
83 | Acne (HP:0001061) | 2.10629942 |
84 | Polyneuropathy (HP:0001271) | 2.09252173 |
85 | Encephalitis (HP:0002383) | 2.09188758 |
86 | IgM deficiency (HP:0002850) | 2.08384557 |
87 | Purpura (HP:0000979) | 2.05323178 |
88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04307549 |
89 | Peritonitis (HP:0002586) | 2.03692385 |
90 | Premature loss of primary teeth (HP:0006323) | 2.00615518 |
91 | Mucopolysacchariduria (HP:0008155) | 1.99592724 |
92 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99592724 |
93 | Slow saccadic eye movements (HP:0000514) | 1.99320730 |
94 | Hepatosplenomegaly (HP:0001433) | 1.96931023 |
95 | Abnormality of iron homeostasis (HP:0011031) | 1.95614370 |
96 | Inflammation of the large intestine (HP:0002037) | 1.94469070 |
97 | Gangrene (HP:0100758) | 1.93909508 |
98 | Cheilitis (HP:0100825) | 1.93898271 |
99 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93770193 |
100 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93770193 |
101 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93770193 |
102 | Subacute progressive viral hepatitis (HP:0006572) | 1.93549401 |
103 | Myocardial infarction (HP:0001658) | 1.92731094 |
104 | Hypergammaglobulinemia (HP:0010702) | 1.92693511 |
105 | Abnormality of T cell physiology (HP:0011840) | 1.92512974 |
106 | Microcytic anemia (HP:0001935) | 1.90961162 |
107 | Abnormality of the prostate (HP:0008775) | 1.89854013 |
108 | Restrictive lung disease (HP:0002091) | 1.89057880 |
109 | Abnormality of the pericardium (HP:0001697) | 1.88826645 |
110 | Colitis (HP:0002583) | 1.88509346 |
111 | Prolonged bleeding time (HP:0003010) | 1.87161655 |
112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87137325 |
113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86816634 |
114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86816634 |
115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86816634 |
116 | Arthralgia (HP:0002829) | 1.86215615 |
117 | Increased IgE level (HP:0003212) | 1.85703261 |
118 | Thrombophlebitis (HP:0004418) | 1.85613417 |
119 | Glomerulonephritis (HP:0000099) | 1.85569584 |
120 | Eosinophilia (HP:0001880) | 1.85104025 |
121 | Viral hepatitis (HP:0006562) | 1.84383839 |
122 | Abnormal platelet volume (HP:0011876) | 1.81111465 |
123 | Skin rash (HP:0000988) | 1.79225038 |
124 | Gastrointestinal inflammation (HP:0004386) | 1.79200890 |
125 | Lymphopenia (HP:0001888) | 1.78947789 |
126 | Amaurosis fugax (HP:0100576) | 1.78622217 |
127 | Glomerulopathy (HP:0100820) | 1.78134669 |
128 | Episodic fever (HP:0001954) | 1.77483483 |
129 | Abnormality of the endocardium (HP:0004306) | 1.76258630 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 4.47952632 |
2 | RIPK4 | 4.25750442 |
3 | IRAK4 | 4.23637524 |
4 | MAP3K14 | 3.84479931 |
5 | IRAK3 | 3.13474496 |
6 | MAP4K1 | 3.12200267 |
7 | STK10 | 3.01933759 |
8 | TBK1 | 2.91622361 |
9 | CSK | 2.44050989 |
10 | ERN1 | 2.38097699 |
11 | FGR | 2.29358886 |
12 | EPHB1 | 2.15741094 |
13 | TYK2 | 2.12451131 |
14 | IKBKB | 2.02260732 |
15 | BTK | 1.86487506 |
16 | TEC | 1.85273453 |
17 | IKBKE | 1.82077613 |
18 | TXK | 1.81795970 |
19 | FES | 1.77721508 |
20 | IRAK1 | 1.74620018 |
21 | CLK1 | 1.69312793 |
22 | IRAK2 | 1.68804167 |
23 | JAK3 | 1.66504578 |
24 | KIT | 1.59108730 |
25 | KSR2 | 1.56324104 |
26 | ZAP70 | 1.49912165 |
27 | HCK | 1.44884375 |
28 | MAP3K12 | 1.37541182 |
29 | TGFBR2 | 1.33260450 |
30 | SYK | 1.29637313 |
31 | RPS6KA4 | 1.28110907 |
32 | PIM2 | 1.24849463 |
33 | CHUK | 1.24204435 |
34 | TAOK3 | 1.20094396 |
35 | MARK3 | 1.17014483 |
36 | LRRK2 | 1.16904241 |
37 | LYN | 1.16753269 |
38 | RIPK1 | 1.14089344 |
39 | PIM1 | 1.14051527 |
40 | CSF1R | 1.10494762 |
41 | MST4 | 1.09556470 |
42 | TRPM7 | 1.09464293 |
43 | PBK | 1.09122510 |
44 | MAP3K2 | 1.06778595 |
45 | JAK1 | 1.02980942 |
46 | PRPF4B | 1.02186243 |
47 | ITK | 0.98324399 |
48 | MAP2K3 | 0.95233717 |
49 | MARK2 | 0.94365930 |
50 | GRK6 | 0.94268344 |
51 | MATK | 0.92805388 |
52 | EIF2AK2 | 0.92062440 |
53 | MAP3K6 | 0.90630240 |
54 | JAK2 | 0.90319530 |
55 | MAP3K10 | 0.89984526 |
56 | PIK3CG | 0.88730053 |
57 | STK24 | 0.85824700 |
58 | LCK | 0.84298748 |
59 | PDPK1 | 0.81193045 |
60 | YES1 | 0.81073843 |
61 | MAP3K13 | 0.80938429 |
62 | ABL2 | 0.80127689 |
63 | EPHA3 | 0.79317853 |
64 | MAP3K11 | 0.78369920 |
65 | GRK7 | 0.77127762 |
66 | PRKCD | 0.76892755 |
67 | MAP3K5 | 0.74973713 |
68 | PRKD2 | 0.73314096 |
69 | MAPK7 | 0.73094089 |
70 | FLT3 | 0.71886246 |
71 | PAK4 | 0.71358476 |
72 | PRKG2 | 0.68698608 |
73 | MAPK12 | 0.66556376 |
74 | PTK6 | 0.64947627 |
75 | MAPKAPK2 | 0.63755366 |
76 | SGK3 | 0.63676975 |
77 | KSR1 | 0.63559959 |
78 | ABL1 | 0.62531470 |
79 | RAF1 | 0.62150785 |
80 | MAP2K4 | 0.61093782 |
81 | RPS6KA6 | 0.59818322 |
82 | DAPK2 | 0.58136782 |
83 | ERBB3 | 0.56969516 |
84 | MAP3K3 | 0.56744191 |
85 | CDK19 | 0.56634210 |
86 | CDC42BPA | 0.56360329 |
87 | MAPK4 | 0.55604033 |
88 | EGFR | 0.54850343 |
89 | MAP3K7 | 0.52582826 |
90 | BMPR2 | 0.51457616 |
91 | WNK1 | 0.51427457 |
92 | BMX | 0.50887674 |
93 | SGK2 | 0.50759437 |
94 | RPS6KC1 | 0.50681770 |
95 | RPS6KL1 | 0.50681770 |
96 | STK4 | 0.49558454 |
97 | STK11 | 0.49179151 |
98 | PRKCQ | 0.48735202 |
99 | SIK3 | 0.47785153 |
100 | ALK | 0.46834258 |
101 | MAP3K1 | 0.46000164 |
102 | HIPK2 | 0.44530704 |
103 | DYRK1B | 0.44372477 |
104 | MAP3K8 | 0.43930916 |
105 | FYN | 0.42906725 |
106 | RPS6KA2 | 0.41626973 |
107 | MOS | 0.41148527 |
108 | RET | 0.39962752 |
109 | STK3 | 0.39702731 |
110 | NLK | 0.39277909 |
111 | TRIB3 | 0.38352383 |
112 | TAOK2 | 0.37110399 |
113 | STK38 | 0.36586090 |
114 | RPS6KA1 | 0.35595667 |
115 | DYRK3 | 0.34218801 |
116 | MST1R | 0.33413283 |
117 | MAP2K6 | 0.33009838 |
118 | TESK2 | 0.32701758 |
119 | FGFR4 | 0.32618508 |
120 | PTK2 | 0.29257969 |
121 | CAMK4 | 0.28941326 |
122 | KDR | 0.28927681 |
123 | SIK2 | 0.28224862 |
124 | PTK2B | 0.27317446 |
125 | PDK1 | 0.25397904 |
126 | TTN | 0.24376580 |
127 | FGFR3 | 0.22772924 |
128 | EIF2AK3 | 0.22570251 |
129 | PKN2 | 0.21299207 |
130 | TNK2 | 0.21117495 |
131 | TAOK1 | 0.17981510 |
132 | NUAK1 | 0.15702352 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 4.01582019 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.38949287 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.98506296 |
4 | Legionellosis_Homo sapiens_hsa05134 | 2.98465570 |
5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.75312506 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67217909 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66150284 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56096375 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 2.52518114 |
10 | Malaria_Homo sapiens_hsa05144 | 2.49588835 |
11 | Pertussis_Homo sapiens_hsa05133 | 2.33754945 |
12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19189729 |
13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18894943 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.02352404 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.01216529 |
16 | Salmonella infection_Homo sapiens_hsa05132 | 1.98451862 |
17 | Asthma_Homo sapiens_hsa05310 | 1.93198179 |
18 | Phagosome_Homo sapiens_hsa04145 | 1.87517386 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.86158348 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86053086 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82625026 |
22 | Measles_Homo sapiens_hsa05162 | 1.82506959 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82001276 |
24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.80672380 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67301627 |
26 | Shigellosis_Homo sapiens_hsa05131 | 1.57367607 |
27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.56758383 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56484580 |
29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54342204 |
30 | Lysosome_Homo sapiens_hsa04142 | 1.51978307 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.50445125 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49848262 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47471136 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39864723 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34322516 |
36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34236432 |
37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32563945 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26207950 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.25003917 |
40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.23000607 |
41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17605567 |
42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13489694 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.12034997 |
44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11786502 |
45 | Amoebiasis_Homo sapiens_hsa05146 | 1.10274818 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04038846 |
47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99637753 |
48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98924809 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97582949 |
50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90041421 |
51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84954318 |
52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82778575 |
53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79852268 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.77568028 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74729808 |
56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68762894 |
57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68111118 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66584461 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65350521 |
60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64236762 |
61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64188979 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63756244 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62471958 |
64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62345536 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62335888 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61576859 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61040801 |
68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60981305 |
69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60976234 |
70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60629877 |
71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58558561 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58156557 |
73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58128477 |
74 | Platelet activation_Homo sapiens_hsa04611 | 0.57622725 |
75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57430521 |
76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56320039 |
77 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55556124 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54103285 |
79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49420067 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.48307388 |
81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.46379497 |
82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45994557 |
83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45540322 |
84 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44372298 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44252572 |
86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44189120 |
87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43916901 |
88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.42753816 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41364315 |
90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39942960 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39646605 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39173709 |
93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38488000 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36811582 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36208562 |
96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34896224 |
97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34796026 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.34581829 |
99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32058554 |
100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31697386 |
101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31565748 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.30994264 |
103 | Mineral absorption_Homo sapiens_hsa04978 | 0.29236151 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.28171225 |
105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27009392 |
106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26774623 |
107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26258054 |
108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24040523 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23077449 |
110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22293680 |
111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20542505 |
112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19095859 |
113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.18030580 |
114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15634459 |
115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14912727 |
116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.14628561 |
117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.11143708 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.09552988 |
119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.06937832 |